The 17q23 amplicon and breast cancer
- PMID: 12755490
- DOI: 10.1023/a:1023081624133
The 17q23 amplicon and breast cancer
Abstract
A novel region of amplification in breast tumors was recently identified on chromosome 17q23. Extensive mapping of the amplicon by Southern blotting and fluorescence in situ hybridization (FISH) in breast cancer cell lines determined that the amplicon can be up to 4 Mbp in size and may contain 50 genes. Copy number analysis at 50-75 kb resolution in breast cancer cell lines and breast tumors identified several independently amplified regions within the amplicon, suggesting that a number of genes are selected for amplification because they independently contribute to tumor formation and progression. Support for this hypothesis comes from studies demonstrating that many of the amplified genes are over-expressed in breast cancer cell lines and tumors, and that the RPS6KB1, TBX2, and PPM1D genes from the region, that are amplified and over-expressed in breast tumors and cell lines, contribute to tumor formation and/or tumor progression. In this review we summarize the structural studies of the amplicon that have been carried out, we outline the evidence implicating the RPS6KB1, TBX2, and PPM1D genes as oncogenes, and we describe some of the other candidate oncogenes from the region.
Similar articles
-
Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer.Proc Natl Acad Sci U S A. 2001 May 8;98(10):5711-6. doi: 10.1073/pnas.091582298. Epub 2001 May 1. Proc Natl Acad Sci U S A. 2001. PMID: 11331760 Free PMC article.
-
Overexpressed genes/ESTs and characterization of distinct amplicons on 17q23 in breast cancer cells.Neoplasia. 2001 Nov-Dec;3(6):521-6. doi: 10.1038/sj.neo.7900187. Neoplasia. 2001. PMID: 11774034 Free PMC article.
-
Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors.Cancer Res. 2001 Jul 1;61(13):4951-5. Cancer Res. 2001. PMID: 11431322
-
Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer.Cancer Lett. 1995 Mar 23;90(1):43-50. doi: 10.1016/0304-3835(94)03676-a. Cancer Lett. 1995. PMID: 7720042 Review.
-
Identifying and validating causal genetic alterations in human breast cancer.Breast Cancer Res Treat. 2003 Apr;78(3):285-7. doi: 10.1023/a:1023078722316. Breast Cancer Res Treat. 2003. PMID: 12755487 Review.
Cited by
-
Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage.Nucleic Acids Res. 2015 Apr 30;43(8):4202-18. doi: 10.1093/nar/gkv223. Epub 2015 Apr 6. Nucleic Acids Res. 2015. PMID: 25845590 Free PMC article.
-
Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence.Sci Transl Med. 2016 Apr 13;8(334):334ra53. doi: 10.1126/scitranslmed.aad3001. Sci Transl Med. 2016. PMID: 27075627 Free PMC article.
-
TRIM37 prevents formation of centriolar protein assemblies by regulating Centrobin.Elife. 2021 Jan 25;10:e62640. doi: 10.7554/eLife.62640. Elife. 2021. PMID: 33491649 Free PMC article.
-
A Bayesian ensemble approach with a disease gene network predicts damaging effects of missense variants of human cancers.Hum Genet. 2013 Jan;132(1):15-27. doi: 10.1007/s00439-012-1218-7. Epub 2012 Aug 21. Hum Genet. 2013. PMID: 22907477
-
Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC.Cell Rep. 2012 Feb 23;1(2):110-7. doi: 10.1016/j.celrep.2011.12.001. Cell Rep. 2012. PMID: 22545246 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous